Q7VRY3 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifqauoanrv2liaom5pwuqzmrw2tt634rgmi5mioi47ynvukphhnpu/metadata.json
IPFS of structure file: 
bafybeiawsf7y2odwhxroarayjuombxir2juyp2qxt2tb2o7rkfopuylggy/AF-Q7VRY3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9E13F516A94FCAecEf11E7A30be20A6A86Bbb8dd
First NFT owner address (bech32): 
genesis1ncfl294ffl9wemc3u73shcs2d2rthwxaz0028c
Current NFT ID #166480 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166480
Accession (UniProt):
Q7VRY3
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
BORDETELLA PERTUSSIS (STRAIN TOHAMA I / ATCC BAA-589 / NCTC 13251)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q7VRY3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q7VRY3|HEM1_BORPE Glutamyl-tRNA reductase OS=Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) OX=257313 GN=hemA PE=3 SV=1 MSVAVLAFGLNHTSAPVSVRERVSMPVDLVKPALEGLRATFGGAVREAAILSTCNRTELYCAAEGQVAEHLPAWLAEHNRLEAAALRPHLYRHQHDDAVRHAFRVASGLDSMVLGEPQILGQMKDAVRAANEAGALGTLLHQLFQRTFSVAKEVRSQTAIGAHSVSMAATAVRLAERVFGQLEDARTLFIGAGEMIELCATHFAAQRPRSMVVANRTIERAETLAGRFSAQTMKLADLTERLAEFDVIVSCTASSLPILGLGMVERATRQRRHRPMVMIDLAVPRDIEPEVGRLDDVYLYSVDDLGRLVQSGTDARRAAVVQAEAIIETRVQGFMHWMQSREVVPVIRDLHQAADDVRAAELERARRMLARGESPEAVLEQLAHGLTQKYLHGPLAALNRSEGDERRQLLAWVPRLFPGRDSRR